Medicine
| ISSN | 20564538 |
|---|---|
| Country | United Kingdom |
| Publisher | Wiley-Blackwell Publishing Ltd |
| Subject Areas | Medicine |
| Publication Type | Journals |
| Active Years | 2015-2020 |
| Competitiveness | No clear consensus |
| Publication Time | No clear consensus |
| Website | Visit journal |
| JIF 2022–2023 | 3.400 |
| 2019-2020 SCR Rank | 2487 |
| 2020-2021 SCR Rank | 1532 |
The Journal of Pathology: Clinical Research and The Journal of Pathology serve as translational bridges between basic biomedical science and clinical medicine with particular emphasis on, but not restricted to, tissue based studies. The focus of The Journal of Pathology: Clinical Research is the publication of studies that illuminate the clinical relevance of research in the broad area of the study of disease. Appropriately powered and validated studies with novel diagnostic, prognostic and predictive significance, and biomarker discover and validation, will be welcomed. Studies with a predominantly mechanistic basis will be more appropriate for the companion Journal of Pathology.
| Year | 2-Year IF | 3-Year IF | 4-Year IF |
|---|---|---|---|
| 2022 | 4.202 | 4.303 | 4.424 |
| 2021 | 4.804 | 4.937 | 4.728 |
| 2020 | 5.021 | 4.569 | 4.911 |
| 2019 | 3.170 | 3.987 | 4.063 |
| 2018 | 3.774 | 3.903 | 3.903 |
| 2017 | 3.521 | 3.542 | 3.542 |
| 2016 | 1.421 | 1.421 | 1.421 |
Note: impact factor data for reference only.
SJR measures scientific influence, weighting citations by the prestige of the citing journal.
| Year | SJR Score |
|---|---|
| 2023 | 1.436 |
| 2022 | 1.288 |
| 2021 | 1.438 |
| 2020 | 1.849 |
| 2019 | 1.864 |
The H-Index measures both the productivity and citation impact of a journal's publications.
| Year | H-Index |
|---|---|
| 2023 | 34.000 |
| 2022 | 30.000 |
| 2021 | 27.000 |
| 2020 | 21.000 |
https://mc.manuscriptcentral.com/jpathclinres